COVID-19

Sascha N Goonewardena1, Qinzhong Chen2, Ashley M Tate1

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor (S.N.G., A.M.T., O.G.G., D.D., P.K.B., S.S.H., D.J.P.).

概括

严重的COVID-19涉及免疫和血液凝固标记物的增加,特别是单细胞中的组织因子. 来自严重病例的血清激活单细胞,突出显示了COVID-19中炎症和血栓形成的机制.